NCT02699151View on ClinicalTrials.gov

INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis

CompletedOBSERVATIONAL
Enrollment

1,210

Participants

Timeline

Start Date

April 14, 2016

Primary Completion Date

August 30, 2019

Study Completion Date

December 31, 2019

Conditions
Superficial Vein Thrombosis
Interventions
DRUG

any drug

Any drug used for the treatment of SVT (e.g. heparin, low-molecular heparin, non-steroidal anti-inflammatory drug, fondaparinux, vitamin K antagonist)

PROCEDURE

any procedure/surgery

Any procedure used for the treatment of SVT(e.g. sclerotherapy, endovenous thermotherapy, crossectomy, stripping, thrombectomy, phlebectomy)

OTHER

Any non-pharmacological treatment of SVT

Any non-pharmacological treatment of SVT (including watchful waiting)

Trial Locations (1)

64283

Gefäßzentrum Darmstadt, Darmstadt

All Listed Sponsors
lead

GWT-TUD GmbH

OTHER

NCT02699151 - INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis | Biotech Hunter | Biotech Hunter